Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53 (-/-) mice.

Vella LA, Yu M, Phillips AB, Finn OJ.

Ann N Y Acad Sci. 2009 Sep;1174:68-73. doi: 10.1111/j.1749-6632.2009.04941.x.

2.

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer.

Vella LA, Yu M, Fuhrmann SR, El-Amine M, Epperson DE, Finn OJ.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14010-5. doi: 10.1073/pnas.0903225106. Epub 2009 Aug 3.

4.

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

Sørensen RB, Andersen RS, Svane IM, Engell-Noerregaard L, Hadrup SR, Balslev E, Andersen MH, thor Straten P.

Clin Cancer Res. 2009 Mar 1;15(5):1543-9. doi: 10.1158/1078-0432.CCR-08-1412. Epub 2009 Feb 17.

5.

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

Kao H, Marto JA, Hoffmann TK, Shabanowitz J, Finkelstein SD, Whiteside TL, Hunt DF, Finn OJ.

J Exp Med. 2001 Nov 5;194(9):1313-23.

6.

Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.

Egloff AM, Vella LA, Finn OJ.

Cancer Res. 2006 Jan 1;66(1):6-9. Review.

7.
8.

p53 regulates a G2 checkpoint through cyclin B1.

Innocente SA, Abrahamson JL, Cogswell JP, Lee JM.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2147-52.

9.

Higher levels of antibodies to the tumour-associated antigen cyclin B1 in cancer-free individuals than in patients with breast cancer.

Pandey JP, Kistner-Griffin E, Namboodiri AM, Iwasaki M, Kasuga Y, Hamada GS, Tsugane S.

Clin Exp Immunol. 2014 Oct;178(1):75-8. doi: 10.1111/cei.12385.

10.
11.

p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.

Innocente SA, Lee JM.

FEBS Lett. 2005 Feb 14;579(5):1001-7. Epub 2005 Jan 13.

12.

Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.

Sypniewska RK, Hoflack L, Tarango M, Gauntt S, Leal BZ, Reddick RL, Gravekamp C.

Breast Cancer Res Treat. 2005 May;91(1):19-28.

PMID:
15868428
13.

Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression.

Yin XY, Grove L, Datta NS, Katula K, Long MW, Prochownik EV.

Cancer Res. 2001 Sep 1;61(17):6487-93.

14.

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

Ersvaer E, Zhang JY, McCormack E, Olsnes A, Anensen N, Tan EM, Gjertsen BT, Bruserud O.

Eur J Haematol. 2007 Sep;79(3):210-25. Epub 2007 Jul 26.

PMID:
17655707
15.

Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer.

Egloff AM, Weissfeld J, Land SR, Finn OJ.

Ann N Y Acad Sci. 2005 Dec;1062:29-40.

PMID:
16461786
16.

Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.

Teramoto K, Kontani K, Fujita T, Ozaki Y, Sawai S, Tezuka N, Fujino S, Itoh Y, Taguchi O, Kannagi R, Ogasawara K.

Cancer Immunol Immunother. 2007 Mar;56(3):331-42. Epub 2006 Aug 5.

PMID:
16896967
17.

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

De Giorgi U, Yuan J, Moroni M, Veronese S, Sartore-Bianchi A, Broggini M, Rosti G, Strebhardt K, Ruffini PA.

Int J Biol Markers. 2015 Jul 22;30(3):e275-81. doi: 10.5301/jbm.5000149.

PMID:
25982682
18.
19.

The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer.

Korenaga D, Takesue F, Yasuda M, Honda M, Nozoe T, Inutsuka S.

Surgery. 2002 Jan;131(1 Suppl):S114-20.

PMID:
11821797
20.

Expression profiling of cyclin B1 and D1 in cervical carcinoma.

Zhao M, Kim YT, Yoon BS, Kim SW, Kang MH, Kim SH, Kim JH, Kim JW, Park YW.

Exp Oncol. 2006 Mar;28(1):44-8.

PMID:
16614707

Supplemental Content

Support Center